Anti-cytokine heterocyclic compounds

US8063094B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Asitha Abeywardane · Danbury, US
• Denise Andersen · Simi Valley, US
• Tina Morwick · New Milford, US
• Roger John Snow · Danbury, US
• Yancey David Ward · Sandy Hook, US

Key dates

• Filing date: Feb 7, 2008
• Grant date: Nov 22, 2011
• Expiry date: Feb 7, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Heterocyclic compounds which are inhibitors of Mitrogen-Activated Protein Kinase-Activated Protein Kinase-2 (MAPKAP-K2) as described, in addition to their use in the treatment of cytokine mediated diseases.